Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Effectiveness of crizotinib versus entrectinib in <i>ROS1</i> -positive non-small-cell lung cancer using clinical and real-world data

PaperCitations, authors & open-access status

Effectiveness of crizotinib versus entrectinib in <i>ROS1</i> -positive non-small-cell lung cancer using clinical and real-world data is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 23 citations, 2022 year and hybrid oa status.

23
Citations
2022
Year
hybrid
OA Status

Related on ScholarIQ

Patrick Daniele
Author
Future Oncology
Journal
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
Pancreatic and Hepatic Oncology Research
Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Topic
470M+ articles · free account